99% Cured of Hep C in Abbott’s Interferon-Free Regimen
Share
Follow Us
Abbott’s Hepatitis C Drugs Clear Virus in 99% of Patients
Bloomberg News
By Ryan Flinn and Drew Armstrong on October 15, 2012
An experimental drug combination from Abbott Laboratories (ABT) wiped out all traces of the virus that causes hepatitis C in 99 percent of patients with the liver disease, a study showed.
The 571 patients in the trial took a two- or three-drug mixture of Abbott therapies for 8 to 24 weeks, along with the antiviral ribavirin. A 79-patient group on the combination of three medicines plus ribavirin for 12 weeks responded best, the Abbott Park, Illinois-based company said today in a statement.
Continue reading this entire article:
http://www.businessweek.com/news/2012-10-15/abbott-s-hepatitis-c-drugs-clear-virus-in-99-percent-of-patients
